WO2006095173A3 - Medical uses of 39-desmethoxyrapamycin and analogues thereof - Google Patents
Medical uses of 39-desmethoxyrapamycin and analogues thereof Download PDFInfo
- Publication number
- WO2006095173A3 WO2006095173A3 PCT/GB2006/000834 GB2006000834W WO2006095173A3 WO 2006095173 A3 WO2006095173 A3 WO 2006095173A3 GB 2006000834 W GB2006000834 W GB 2006000834W WO 2006095173 A3 WO2006095173 A3 WO 2006095173A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- desmethoxyrapamycin
- analogues
- medical uses
- medical
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002599547A CA2599547A1 (en) | 2005-03-11 | 2006-03-10 | Medical uses of 39-desmethoxyrapamycin and analogues thereof |
BRPI0608726-4A BRPI0608726A2 (en) | 2005-03-11 | 2006-03-10 | use of a 39-demethoxy pyramycin analog or a pharmaceutically acceptable salt thereof, and, pharmaceutical composition |
EP06710048A EP1896018A2 (en) | 2005-03-11 | 2006-03-10 | Medical uses of 39-desmethoxyrapamycin and analogues thereof |
US11/908,367 US20100061994A1 (en) | 2005-03-11 | 2006-03-10 | Medical uses of 39-desmethoxyrapamycin and analogues thereof |
MX2007011132A MX2007011132A (en) | 2005-03-11 | 2006-03-10 | Medical uses of 39-desmethoxyrapamycin and analogues thereof. |
NZ561647A NZ561647A (en) | 2005-03-11 | 2006-03-10 | Medical uses of 39-desmethoxyrapamycin and analogues thereof |
JP2008500265A JP2008534442A (en) | 2005-03-11 | 2006-03-10 | Uses of compounds |
AU2006221774A AU2006221774A1 (en) | 2005-03-11 | 2006-03-10 | Medical uses of 39-desmethoxyrapamycin and analogues thereof |
IL185548A IL185548A0 (en) | 2005-03-11 | 2007-08-27 | Medical uses of 39-desmethoxyrapamycin and analogues thereof |
NO20074661A NO20074661L (en) | 2005-03-11 | 2007-09-13 | Use of a compound |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0504995.2A GB0504995D0 (en) | 2005-03-11 | 2005-03-11 | Use of a compound |
GB0504995.2 | 2005-03-11 | ||
US11/097,605 US7183289B2 (en) | 2005-03-11 | 2005-04-01 | 39-desmethoxyrapamycin, compositions and methods of use thereof |
US11/097,605 | 2005-04-01 | ||
GB0522829A GB0522829D0 (en) | 2005-11-09 | 2005-11-09 | Use of a compound |
GB0522829.1 | 2005-11-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006095173A2 WO2006095173A2 (en) | 2006-09-14 |
WO2006095173A3 true WO2006095173A3 (en) | 2007-01-11 |
Family
ID=36659697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2006/000834 WO2006095173A2 (en) | 2005-03-11 | 2006-03-10 | Medical uses of 39-desmethoxyrapamycin and analogues thereof |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1896018A2 (en) |
KR (1) | KR20070116868A (en) |
AU (1) | AU2006221774A1 (en) |
CA (1) | CA2599547A1 (en) |
NO (1) | NO20074661L (en) |
WO (1) | WO2006095173A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0504995D0 (en) * | 2005-03-11 | 2005-04-20 | Biotica Tech Ltd | Use of a compound |
GB0504994D0 (en) | 2005-03-11 | 2005-04-20 | Biotica Tech Ltd | Novel compounds |
WO2017040341A1 (en) * | 2015-08-28 | 2017-03-09 | Buck Institute For Research On Aging | RAPAMYCIN ANALOGS SHOWING IMPROVED mTORC1 SPECIFICITY |
CN111760015A (en) * | 2020-01-21 | 2020-10-13 | 中南大学 | Application of micafungin in preparation of neuroprotective drugs |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206018A (en) * | 1978-11-03 | 1993-04-27 | Ayerst, Mckenna & Harrison, Inc. | Use of rapamycin in treatment of tumors |
WO2004007709A2 (en) * | 2002-07-16 | 2004-01-22 | Biotica Technology Limited | Production of polyketides |
WO2006016167A2 (en) * | 2004-08-11 | 2006-02-16 | Biotica Technology Limited | 17-desmethylrapamycin and analogues thereof, methods for their roduction and their use as immunosupressants, anticancer agents, antifungal agents, etc. |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5023262A (en) | 1990-08-14 | 1991-06-11 | American Home Products Corporation | Hydrogenated rapamycin derivatives |
US5221670A (en) | 1990-09-19 | 1993-06-22 | American Home Products Corporation | Rapamycin esters |
US5138051A (en) | 1991-08-07 | 1992-08-11 | American Home Products Corporation | Rapamycin analogs as immunosuppressants and antifungals |
EP0586512A1 (en) | 1991-05-31 | 1994-03-16 | Pfizer Inc. | Use of rapamycin prodrugs as immunosuppressant agents |
ZA935112B (en) | 1992-07-17 | 1994-02-08 | Smithkline Beecham Corp | Rapamycin derivatives |
GB9221220D0 (en) | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
US5373014A (en) | 1993-10-08 | 1994-12-13 | American Home Products Corporation | Rapamycin oximes |
US5391730A (en) | 1993-10-08 | 1995-02-21 | American Home Products Corporation | Phosphorylcarbamates of rapamycin and oxime derivatives thereof |
US5378836A (en) | 1993-10-08 | 1995-01-03 | American Home Products Corporation | Rapamycin oximes and hydrazones |
NZ277498A (en) | 1993-12-17 | 1998-03-25 | Novartis Ag | Rapamycin derivatives |
US5362718A (en) | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
US5563145A (en) | 1994-12-07 | 1996-10-08 | American Home Products Corporation | Rapamycin 42-oximes and hydroxylamines |
CN1124276C (en) | 1995-06-09 | 2003-10-15 | 诺瓦蒂斯有限公司 | Rapamycin derivatives |
US5780462A (en) | 1995-12-27 | 1998-07-14 | American Home Products Corporation | Water soluble rapamycin esters |
AU730781B2 (en) | 1996-07-30 | 2001-03-15 | Novartis Ag | Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxiethyl)-rapamycin |
US6015815A (en) | 1997-09-26 | 2000-01-18 | Abbott Laboratories | Tetrazole-containing rapamycin analogs with shortened half-lives |
GB0504994D0 (en) * | 2005-03-11 | 2005-04-20 | Biotica Tech Ltd | Novel compounds |
-
2006
- 2006-03-10 CA CA002599547A patent/CA2599547A1/en not_active Abandoned
- 2006-03-10 WO PCT/GB2006/000834 patent/WO2006095173A2/en active Application Filing
- 2006-03-10 KR KR1020077023041A patent/KR20070116868A/en not_active Application Discontinuation
- 2006-03-10 AU AU2006221774A patent/AU2006221774A1/en not_active Abandoned
- 2006-03-10 EP EP06710048A patent/EP1896018A2/en not_active Withdrawn
-
2007
- 2007-09-13 NO NO20074661A patent/NO20074661L/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206018A (en) * | 1978-11-03 | 1993-04-27 | Ayerst, Mckenna & Harrison, Inc. | Use of rapamycin in treatment of tumors |
WO2004007709A2 (en) * | 2002-07-16 | 2004-01-22 | Biotica Technology Limited | Production of polyketides |
WO2006016167A2 (en) * | 2004-08-11 | 2006-02-16 | Biotica Technology Limited | 17-desmethylrapamycin and analogues thereof, methods for their roduction and their use as immunosupressants, anticancer agents, antifungal agents, etc. |
Non-Patent Citations (5)
Title |
---|
GREGORY M A ET AL: "566 Novel mTOR inhibitors with improved pharmacological properties over rapamycin", EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, PERGAMON, OXFORD, GB, vol. 2, no. 8, September 2004 (2004-09-01), pages 172, XP004640010, ISSN: 1359-6349 * |
GREGORY MATTHEW A ET AL: "Mutasynthesis of rapamycin analogues through the manipulation of a gene governing starter unit biosynthesis.", ANGEWANDTE CHEMIE (INTERNATIONAL ED. IN ENGLISH) 25 JUL 2005, vol. 44, no. 30, 25 July 2005 (2005-07-25), pages 4757 - 4760, XP009069971, ISSN: 0570-0833 * |
HAMILTON G S ET AL: "NEUROIMMUNOPHILIN LIGANDS AS NOVEL THERAPEUTICS FOR THE TREATMENT OF DEGENERATIVE DISORDERS OF THE NERVOUS SYSTEM", CURRENT PHARMACEUTICAL DESIGN, BENTHAM SCIENCE PUBLISHERS, SCHIPHOL, NL, vol. 3, no. 4, 1997, pages 405 - 428, XP000980342, ISSN: 1381-6128 * |
LOWDEN PHILIP A S ET AL: "New rapamycin derivatives by precursor-directed biosynthesis.", CHEMBIOCHEM : A EUROPEAN JOURNAL OF CHEMICAL BIOLOGY. 2 APR 2004, vol. 5, no. 4, 2 April 2004 (2004-04-02), pages 535 - 538, XP002391986, ISSN: 1439-4227 * |
See also references of EP1896018A2 * |
Also Published As
Publication number | Publication date |
---|---|
CA2599547A1 (en) | 2006-09-14 |
EP1896018A2 (en) | 2008-03-12 |
WO2006095173A2 (en) | 2006-09-14 |
AU2006221774A1 (en) | 2006-09-14 |
KR20070116868A (en) | 2007-12-11 |
NO20074661L (en) | 2007-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1919302B8 (en) | Food comprising silicon | |
UA94221C2 (en) | Lipocalin protein | |
WO2007044026A3 (en) | Compositions comprising modified collagen and uses therefore | |
WO2005097825A3 (en) | Bmp-7 variants with improved properties | |
WO2008034013A3 (en) | Medical devices and methods of making the same | |
WO2007082923A3 (en) | Use of protein microbeads in cosmetics | |
WO2008100805A3 (en) | Anti-robo4 antibodies and uses therefor | |
WO2007127841A3 (en) | Compositions and methods of preparation thereof | |
PL1913138T3 (en) | Processes for the manufacture of pancreatin powder with low virus content | |
EP1879659A4 (en) | Low-irritation compositions and methods of making the same | |
WO2006124748A3 (en) | Multicyclic compounds and methods of their use | |
WO2006114439A3 (en) | Novel nutraceutical compositions | |
WO2007133290A8 (en) | Anti-ox40l antibodies and methods using same | |
WO2006117217A3 (en) | Novel use of spiegelmers | |
WO2006124713A3 (en) | 4-biarylyl-1-phenylazetidin-2-ones | |
WO2007130697A8 (en) | Anti-ephb4 antibodies and methods using same | |
WO2010077740A3 (en) | Novel antiviral compounds, compositions, and methods of use | |
EP1863800A4 (en) | Synthesis of avrainvillamide, stephacidin b, and analogues thereof | |
WO2007025146A3 (en) | Balsalazide formulations and manufacture and use thereof | |
TW200732410A (en) | Sprayable acoustic compositions | |
WO2007127506A3 (en) | Anti-ephrinb2 antibodies and methods using same | |
WO2007067784A3 (en) | Liposomal compositions | |
WO2007022321A3 (en) | Substituted indoles and use thereof | |
WO2010046061A3 (en) | Cosmetic and/or pharmaceutical formulations | |
WO2006081337A3 (en) | Erastin analogues and their uses for killing cancer cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 185548 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2599547 Country of ref document: CA Ref document number: 12007501837 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/011132 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008500265 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 561647 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006221774 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 7407/DELNP/2007 Country of ref document: IN |
|
REEP | Request for entry into the european phase |
Ref document number: 2006710048 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006710048 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 07101635 Country of ref document: CO |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077023041 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007137669 Country of ref document: RU Ref document number: 1200702089 Country of ref document: VN Ref document number: CR2007-009435 Country of ref document: CR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200680012675.1 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 2006221774 Country of ref document: AU Date of ref document: 20060310 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2006221774 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006710048 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11908367 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0608726 Country of ref document: BR Kind code of ref document: A2 Effective date: 20070911 |